Clinical Trial

Azithromycin Treatment for the Airway Microbiome in Asthma

Study Description

Azithromycin Treatment for the Airway Microbiome in Asthma

The purpose of this study to determine whether the bacteria inside the lungs of people with asthma can be modified (changed) if they are given an antibiotic and if this change is associated with an improvement in asthma symptoms.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - Azithromycin

8 weeks of Azithromycin (250 mg) once daily by mouth

Drug - Placebo

Placebo

Additional Information

Official Study Title

The AZITRAMBA Trial: Azithromycin Treatment for the Airway Microbiome in Asthma

Clinical Trial ID

NCT03736629

ParticipAid ID

azpB8d